Light therapy could replace surgery for rare urinary tract cancer
Disease control
Recruiting now
This study tests a drug called TOOKAD (padeliporfin) that is activated by light to destroy low-grade tumors in the kidney or ureter. About 100 adults with this rare cancer will receive the treatment in two phases and be followed for up to 4 years. The goal is to see if the drug c…
Phase: PHASE3 • Sponsor: Steba Biotech S.A. • Aim: Disease control
Last updated May 08, 2026 12:03 UTC